Neonatal nonepileptic myoclonus is a prominent clinical feature of KCNQ 2 gain‐of‐function variants R201C and R201H
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Summary: Objective: To analyze whether KCNQ 2 R201C and R201H variants, which show atypical gain‐of‐function electrophysiologic properties in vitro, have a distinct clinical presentation and outcome. Methods: Ten children with heterozygous, de novo KCNQ 2 R201C or R201H variants were identified worldwide, using an institutional review board (IRB)–approved KCNQ 2 patient registry and database. We reviewed medical records and, where possible, interviewed parents and treating physicians using a structured, detailed phenotype inventory focusing on the neonatal presentation and subsequent course. Results: Nine patients had encephalopathy from birth and presented with prominent startle‐like myoclonus, which could be triggered by sound or touch. In seven patients, electroencephalography (EEG) was performed in the neonatal period and showed a burst‐suppression pattern. However, myoclonus did not have an EEG correlate. In many patients the paroxysmal movements were misdiagnosed as seizures. Seven patients developed epileptic spasms in infancy. In all patients, EEG showed a slow background and multifocal epileptiform discharges later in life. Other prominent features included respiratory dysfunction (perinatal respiratory failure and/or chronic hypoventilation), hypomyelination, reduced brain volume, and profound developmental delay. One patient had a later onset, and sequencing indicated that a low abundance (~20%) R201C variant had arisen by postzygotic mosaicism. Significance: Heterozygous KCNQ 2 R201C and R201H gain‐of‐function variants present with profound neonatal encephalopathy in the absence of neonatal seizures. Neonates present with nonepileptic myoclonus that is often misdiagnosed and treated as seizures. Prognosis is poor. This clinical presentation is distinct from the phenotype associated with loss‐of‐function variants, supporting the value of in vitro functional screening. These findings suggest that gain‐of‐function and loss‐of‐function variants need different targeted therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns
Singh, N. A., Charlier, C., Stauffer, D., DuPont, B. R., Leach, R. J., Melis, R., Ronen, G. M., Bjerre, I., Quattlebaum, T., Murphy, J. V., et al. (1998) · Nature Genetics · doi:10.1038/ng0198-25 · Cited by 1,199
A Potassium Channel Mutation in Neonatal Human Epilepsy
Biervert, C., Schroeder, B. C., Kubisch, C., Berkovic, S. F., Propping, P., Jentsch, T. J., & Steinlein, O. K. (1998) · Science · doi:10.1126/science.279.5349.403 · Cited by 1,073
Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1
Carvill, G. L., Heavin, S. B., Yendle, S. C., McMahon, J. M., O'Roak, B. J., Cook, J., Khan, A., Dorschner, M. O., Weaver, M., Calvert, S., et al. (2013) · Nature Genetics · doi:10.1038/ng.2646 · Cited by 687
Self-citationBrown, D. A., & Passmore, G. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00111.x · Cited by 676
KCNQ2 encephalopathy: Emerging phenotype of a neonatal epileptic encephalopathy
Weckhuysen, S., Mandelstam, S., Suls, A., Audenaert, D., Deconinck, T., Claes, L. R. F., Deprez, L., Smets, K., Hristova, D., Yordanova, I., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22644 · Cited by 514
Self-citationEarly patterns of electrical activity in the developing cerebral cortex of humans and rodents
Khazipov, R., & Luhmann, H. J. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.007 · Cited by 482
Miceli, F., Soldovieri, M. V., Ambrosino, P., De Maria, M., Migliore, M., Migliore, R., & Taglialatela, M. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4423-14.2015 · Cited by 191 · cited 2×
“, to date, R144Q, V175L, R201C, R201H, and R198Q) produce gain-of-function effects by shifting activation to more hyperpolarized potentials and/or increasingmaximal current density.(14,18,19) Both de novo loss-of-function and the R201C/H gain-offunction variants lead to a neonatal encephalopathy characterized by a bur…”
BackgroundResultSelf-citationMillichap, J. J., Miceli, F., De Maria, M., Keator, C., Joshi, N., Tran, B., Soldovieri, M. V., Ambrosino, P., Shashi, V., Mikati, M. A., et al. (2017) · Epilepsia · doi:10.1111/epi.13601 · Cited by 103
Self-citation
Cited by
Pressler, R. M., Cilio, M. R., Mizrahi, E. M., Moshé, S. L., Nunes, M. L., Plouin, P., Vanhatalo, S., Yozawitz, E., de Vries, L. S., Puthenveettil Vinayan, K., et al. (2021) · Epilepsia · doi:10.1111/epi.16815 · Cited by 365
Self-citationTargeting Kv7 Potassium Channels for Epilepsy
Perucca, E., & Taglialatela, M. (2025) · CNS Drugs · doi:10.1007/s40263-024-01155-3 · Cited by 43
“…variants have been reported in a small subset of patients with distinct neurodevelopmental disorders, including infantile spasms without prior neonatal seizures [73], or severe neonatal-onset encephalopathy with prominent startle-like myoclonus and a burst-suppression EEG pattern [74].”
Self-citationCarotenuto, L., Keminer, O., Carleo, G., Zaliani, A., Leo, A., Citraro, R., De Sarro, G., Dirkx, N., Kaji, M., Weckhuysen, S., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70119 · Cited by 10
“…glutamatergic neurons (iNeurons) differentiated from CRISPR/Cas9-corrected (isogenic) induced-pluripotent stem cells (hiPSC) from a patient carrying a DEE-causing KCNQ2 variant ( KCNQ2 R201C/ + ) (Mulkey et al., 2017) were used (as described in Section 2 and Supporting Information Methods section).”
Self-citationZahra, A., Liu, R., Wang, J., & Wu, J. (2023) · Neurological Sciences · doi:10.1007/s10072-023-06955-x · Cited by 9
Metadata
- Authors
- Mulkey, S. B., Ben‐Zeev, B., Nicolai, J., Carroll, J. L., Grønborg, S., Jiang, Y., Joshi, N., Kelly, M., Koolen, D. A., Mikati, M. A., Park, K., Pearl, P. L., Scheffer, I. E., Spillmann, R. C., Taglialatela, M., Vieker, S., Weckhuysen, S., Cooper, E. C., & Cilio, M. R.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2017-01-31
- Volume
- 58
- Issue
- 3
- Pages
- 436-445
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2583480219
- Cited by
- 108
- References
- 8
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neonatal nonepileptic myoclonus is a prominent clinical feature of KCNQ 2 gain‐of‐function variants R201C and R201H. https://app.cochat.ai/papers/10.1111/epi.13676
- The paper
- Mulkey, S. B., Ben‐Zeev, B., Nicolai, J., Carroll, J. L., Grønborg, S., Jiang, Y., Joshi, N., Kelly, M., Koolen, D. A., Mikati, M. A., Park, K., Pearl, P. L., Scheffer, I. E., Spillmann, R. C., Taglialatela, M., Vieker, S., Weckhuysen, S., Cooper, E. C., & Cilio, M. R. (2017). Neonatal nonepileptic myoclonus is a prominent clinical feature of KCNQ 2 gain‐of‐function variants R201C and R201H. Epilepsia. https://doi.org/10.1111/epi.13676
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.